Lynchburg City Council proposes increasing ambulance service rates
A public hearing is scheduled for June 10 during a regular City Council meeting to discuss new ambulance service rates as proposed by a third-party billing vendor for the Lynchburg Fire Department, at the request of the council.
City County officials said there have been no rate changes of this kind since 2018 and would align charges with the 150% Medicare rate method, which is currently the standard industry practice for the region.
Lynchburg Fire Department anointed new engine with traditional ceremony
This would mean a projected revenue increase of around $200,000 annually. Non-Emergency Basic Life Support services would increase from $350.00 to $422.07, and Emergency Basic Life Support services would increase from $500.00 to $675.30. Additionally, there would be a per-mile charge increase of $1.73, from $12.00 to $13.73.
There would be no changes to oxygen supply and non-transport fee charges.
Service
Current
2025 Proposed
Net Change
BLS non-emergency
$350.00
$422.07
+$72.07
BLS Emergency
$500.00
$675.30
+$175.30
ALS non-emergency
$425.00
$506.48
+$81.48
ALS Emergency – Level 1
$600.00
$801.92
+$201.92
ALS Emergency – Level 2
$850.00
$1,160.66
+$310.66
Specialty Care (APP)
N/A
$1,371.69
+$1,371.69
Charge Per Mile
$12.00
$13.73
+$1.73
Oxygen Supply Charge
$50.00
$50.00
$0.00
Non-Transport Fee
$100.00
$100.00
$0.00
The change would amend Section 5-6 of Article I of Chapter 5 of the Code of the City from 1981 that addresses technical changes, rate increases, and new fees for ambulance and related services provided by the Lynchburg Fire Department.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 hours ago
- Yahoo
Karoline Leavitt Hints Trump Could Start Hiding Even More Jobs Data
The Trump administration appears to be inching away from the responsibility of issuing a monthly jobs report. Speaking with reporters at a White House press briefing Tuesday, press secretary Karoline Leavitt failed to promise that the economic updates would continue, instead downgrading their existence to a 'hope' while further undermining the credibility of the data the reports are built upon. 'Will the Bureau of Labor Statistics continue to put out monthly jobs reports?' asked a reporter. 'Well, look, what I'll tell you about the Bureau of Labor Statistics—I believe that is the plan and that's the hope, and that these monthly reports will be data that the American people can trust,' Leavitt said. 'As you know, the Bureau of Labor Statistics has made massive revisions after the last several points reports that they have put out. 'And there has certainly been a decline in the quality and reliability of data coming from the Bureau of Labor Statistics, and there's been an increase in revisions,' Leavitt continued. 'And this president and the administration is finally tackling this problem that so many have talked about. The president is actually doing something about it.' Donald Trump's new nominee for BLS commissioner, E.J. Antoni, told Fox Business Tuesday that 'BLS should suspend issuing the monthly job reports' and instead only rely on quarterly data. Prior to entering the fold of the Trump administration, Antoni worked as the Heritage Foundation's chief economist and helped develop Project 2025. Trump abruptly fired BLS's last commissioner, Erika McEntarfer, hours after the release of the last jobs report, claiming that the Biden-era appointee's work analyzing the granular data of America's economy was 'faked' and could not be trusted. Revisions to the monthly jobs report are far from out of the ordinary. Instead, it's fairly normal for the reports to tell a different picture month-to-month, as more data is collected over time from late-submitting survey participants. The report has been published on a monthly basis since 1916, but there hasn't been an issue with it until Trump 2.0. At the core of Trump's gripe with the July report was its revision of figures from the preceding months, which moved the three-month growth average to 35,000. A lag like that hasn't emerged since 2010, and it made Trump's first six months in office—and his controversial tariff overhaul—look particularly bad. The report's downsizing also suggested that while some sectors, such as health care and social assistance, gained jobs, the vast majority of the market lost employment. The absence of a monthly report would be yet another infringement on transparency and accountability between the federal government and the people it's supposed to represent. 'We need to look at the means and the methods of how the United States is acquiring this very important data,' Leavitt said Tuesday. 'The goal, of course, is to provide honest and good data for the American people to make very important economic decisions on.'
Yahoo
9 hours ago
- Yahoo
New Medicare program offers much-needed relief for caregivers of dementia patients
A new Medicare program covering services for at-home nursing care for dementia patients has received the green light to expand nationwide following a yearlong pilot program. It's a first for Medicare, spotlighting the needs of the more than 11 million unpaid family caregivers of people with dementia. The voluntary program, called GUIDE (Guiding an Improved Dementia Experience), initially started with a Biden administration executive order to test a new model focused on dementia care that pays for some family caregiver support. 'For unpaid caregivers, who face not only difficult care responsibilities and decisions, but also serious financial consequences with few opportunities for help with training or short-term respite breaks, the program is a significant start,' Cindy Hounsell, founder and president of the Women's Institute for a Secure Retirement (WISER), told Yahoo Finance. Approximately two-thirds of dementia caregivers are women, according to Centers for Disease Control and Prevention (CDC) data. The GUIDE program is now offered in 45 states — all but Alaska, the Dakotas, Kansas, and Mississippi — and includes roughly 330 Medicare-participating providers, including large academic medical centers, hospital health systems, small group practices, community-based organizations, and hospice agencies. The initiative has been approved for an eight-year run. More than 6.9 million people in the US are living with dementia stemming from a range of diseases such as Alzheimer's and Parkinson's, according to a 2024 report from the National Institutes of Health. As the population in the US ages, cases are expected to jump to nearly 14 million by 2060. Most people with dementia in the US live at home. About 8 in 10 adults with dementia live in their homes with spouses or other family members, according to the CDC. How it works Eligible patients must be enrolled in Medicaid or original Medicare — not Medicare Advantage. To qualify, patients must have a diagnosis of moderate to severe dementia and not live in an assisted care facility, nursing home, or be receiving hospice care. They must also be patients of a participating provider. The program pays up to $2,500 each year per beneficiary for respite benefits, which cover the cost for in-home caregivers, overnight care, or adult day care. Last year, the national median pay for home health and personal care aides was $16.78 per hour. Translation: the program could cover 148 hours of in-home care, giving family caregivers a chance to take a break. The program doesn't provide Medicare patients with the funds to directly pay these caregivers who step in to lend a hand. It provides Medicare payments to those provider organizations that, in turn, cover the caregiver's pay. In addition, the program includes round-the-clock access to a support line to connect directly to a licensed nurse who can answer questions. This is particularly useful in case of emergencies and can defray a hospital visit in some cases, Hounsell said. Many family caregivers aren't trained to handle medical or nursing tasks such as managing catheters, performing injections, or monitoring vital signs. To address this gap, the new Medicare initiative provides access to caregiver training and education. Sign up for the Mind Your Money weekly newsletter By subscribing, you are agreeing to Yahoo's Terms and Privacy Policy Savings are two-fold Ideally, the program will cut costs for Medicare in fewer emergency room visits and short-term hospital stays for those with dementia. For families of those with dementia, the end goal is to help those patients stay at home longer and avoid the high cost of assisted care or nursing homes, which can be a massive drain on a family's finances. It often comes as a shock to people that Medicare doesn't cover the cost of long-term care facilities, which can quickly top tens of thousands of dollars. An apartment in an assisted-living facility had an average rate of $74,148 a year in 2024, according to the National Investment Center for Seniors Housing & Care — and costs go up as residents age and need more care. Units for dementia patients can run more than $94,000. 'Alternative payment models like this are critical to helping individuals remain in the setting of their choice,' said Mollie Gurian, vice president for policy and government affairs at LeadingAge, an association of nonprofit providers of aging services. 'These participating providers understand the complexity of caring for older adults with dementia and recognize that family and friends are essential members of the care team.' Kerry Hannon is a Senior Columnist at Yahoo Finance. She is a career and retirement strategist and the author of 14 books, including the forthcoming "Retirement Bites: A Gen X Guide to Securing Your Financial Future," "In Control at 50+: How to Succeed in the New World of Work," and "Never Too Old to Get Rich." Follow her on Bluesky. Sign up for the Mind Your Money newsletter Sign in to access your portfolio
Health Line
10 hours ago
- Health Line
Does Medicare Cover Saxenda for weight loss?
Saxenda (liraglutide) is a GLP-1 agonist injection pen medication used to support long-term weight loss in adults with obesity, adults with overweight and weight-related health issues, and certain children. Doctors usually prescribe it as part of a comprehensive weight management plan that includes dietary changes and regular exercise. Does Medicare cover Saxenda for older adults? Medicare drug plans don't cover Saxenda because Medicare doesn't cover GLP-1 agonists when prescribed for weight loss. Medicare may cover some GLP-1 agonists when prescribed to treat another health condition, like diabetes. However, the Food and Drug Administration (FDA) only approves prescribing Saxenda for weight loss, meaning Medicare doesn't cover the drug. How much is a 30-day supply of Saxenda? Without insurance coverage, Saxenda isn't cheap. One injection package costs around $1,400. You may be able to afford Saxenda via the manufacturer's savings program, which reduces the price to $25 per box. Contact the manufacturer to verify your eligibility. According to the manufacturer, this drug's availability is currently limited due to significant demand. So, you may, in some cases, have difficulty filling your prescription. Is there a weight loss drug covered by Medicare? The government set a goal to broaden Medicare and Medicaid coverage of GLP-1 drugs for weight loss alone by 2026. But the current administration abandoned the initiative. However, if you have diabetes, you can get alternative GLP-1 agonists covered through Medicare if prescribed to treat your disease rather than for weight loss. These include Mounjaro (tirzepatide) and Ozempic (semaglutide). If you have obesity, you can get Wegovy (semaglutide) if you're at a high risk of heart attack or stroke. How do I know if my insurance covers an alternative to Saxenda? If you're eligible for coverage of one of the aforementioned GLP-1 agonists based on your health, your Medicare drug plan should generally cover some of these drugs. The GLP-1 drugs you can get through Medicare Part D or a Medicare Advantage prescription drug (MAPD) plan, and how much you may pay out of pocket after coverage, will depend on your specific plan. The information on this website may assist you in making personal decisions about insurance, but it is not intended to provide advice regarding the purchase or use of any insurance or insurance products. Healthline Media does not transact the business of insurance in any manner and is not licensed as an insurance company or producer in any U.S. jurisdiction. Healthline Media does not recommend or endorse any third parties that may transact the business of insurance.
